| Literature DB >> 27780241 |
Wei-Hung Chan1, Meei-Shyuan Lee2, Chin Lin3, Chang-Chieh Wu4, Hou-Chuan Lai1, Shun-Ming Chan1, Chueng-He Lu1, Chen-Hwan Cherng1, Zhi-Fu Wu1.
Abstract
We conducted a retrospective study to investigate the anesthesia-controlled time and factors that contribute to prolonged extubation in open colorectal surgery. Using our hospital database, demographic data, various time intervals (waiting for anesthesia time, anesthesia time, surgical time, emergence time, exit from operating room after extubation, total operating room time, and post-anesthesia care unit stay time), and incidence of prolonged extubation (≥ 15 mins), were compared between patients who received desflurane/fentanyl-based anesthesia and total intravenous anesthesia via target-controlled infusion with fentanyl/propofol. Logistic regression analyses were performed to assess the association between variables that contributed to prolonged extubation. In conclusion, the anesthesia-controlled time was similar in desflurane anesthesia and propofol-based total intravenous anesthesia for open colorectal surgery in our hospital. Surgical time greater than 210 minutes, as well as age, contributed to prolonged extubation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27780241 PMCID: PMC5079552 DOI: 10.1371/journal.pone.0165407
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The flow diagram.
TIVA = total intravenous anesthesia; DES = desflurane anesthesia.
Comparison of patient characteristics.
| Group DES (n = 219) | Group TIVA (n = 176) | P value | |
|---|---|---|---|
| ASA II/III | 148/71 | 125/51 | 0.13 |
| Gender (Male/Female) | 123/96 | 98/78 | 1.00 |
| Age (y/o) | 63.5 ± 11.5 | 65.0 ± 10.0 | 0.16 |
| Height (cm) | 163.1 ± 8.0 | 162.8 ± 8.3 | 0.70 |
| Weight (kg) | 63.7 ± 12.5 | 63.6 ± 12.3 | 0.94 |
| BMI (kg/m2) | 23.8 ± 3.7 | 23.9 ± 3.8 | 0.84 |
DES, desflurane anesthesia; TIVA, total intravenous anesthesia; ASA, American Society of Anesthesiologists; BMI, body mass index.
Data are shown as mean ± standard deviation or number.
Comparison of the amount of opioid, non-depolarizing muscle relaxants, and reversal agents used during surgical periods between the DES and TIVA groups.
| Group DES (n = 219) | Group TIVA (n = 176) | P value | |
|---|---|---|---|
| Fentanyl (μg/kg) | 2.9 ± 0.7 | 4.5 ± 1.0 | <0.001 |
| Cisatracurium (mg/kg) | 0.2 ± 0.1 | 0.3 ± 0.1 | <0.001 |
| Neostigmine (μg/kg) | 32.2 ± 4.4 | 33.0 ± 4.4 | 0.08 |
| Glycopyrrolate (μg/kg) | 6.4 ± 0.9 | 06.5 ± 0.9 | 0.08 |
DES, desflurane anesthesia; TIVA, total intravenous anesthesia.
Data are shown as mean ± SD or number.
Comparison of operating room time between the DES and TIVA groups.
| Group DES (n = 219) | Group TIVA (n = 176) | P value | |
|---|---|---|---|
| Waiting for anesthesia time (min) | 7.8 ± 3.5 | 7.7 ± 3.7 | 0.81 |
| Surgical time (min) | 178.7 ± 45.7 | 180.1 ± 42.7 | 0.77 |
| Anesthesia time (min) | 214.6 ± 46.7 | 214.1 ± 45.1 | 0.90 |
| Extubation time (min) | 9.8 ± 4.4 | 9.5 ± 3.8 | 0.39 |
| Exit from operating room after extubation (min) | 9.4 ± 2.7 | 9.2 ± 2.7 | 0.63 |
| Total operating room time (min) | 231.8 ± 47.0 | 230.8 ± 46.1 | 0.84 |
| PACU time (min) | 49.8 ± 12.3 | 49.9 ± 11.7 | 0.94 |
DES, desflurane anesthesia; TIVA, total intravenous anesthesia; PACU, post-anesthesia care unit.
Data are shown as mean ± SD or number.
Univariate and multivariate logistic regression analyses of variables associated with prolonged extubation in all patients (n = 395).
| Variables | n1/n2 | Crude Model | Multivariable Model | ||||
|---|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | p value | Odds ratio | 95% CI | |||
| Surgical time (min) | |||||||
| ≤ 210 (ref.) | 15/300 | 1.00 | 1.00 | - | - | ||
| 211–240 | 14/39 | 7.18 | 3.22–16.0 | <0.001 | 8.10 | 3.51–18.7 | <0.001 |
| > 240 | 19/8 | 47.5 | 17.9–126 | <0.001 | 64.7 | 21.8–192 | <0.001 |
| | <0.001 | <0.001 | |||||
| Women (ref: Men) | 0.66 | 0.35–1.24 | 0.68 | 0.31–1.46 | 0.32 | ||
| Age, y/o | |||||||
| Q1: 29–55 (ref.) | 8/80 | 1.00 | - | - | 1.00 | - | - |
| Q2: 56–60 | 7/65 | 1.08 | 0.37–3.13 | 0.89 | 1.44 | 0.40–5.21 | 0.58 |
| Q3: 61–68 | 14/69 | 2.03 | 0.80–5.12 | 0.13 | 2.05 | 0.62–6.73 | 0.24 |
| Q4: 69–75 | 11/68 | 1.62 | 0.62–4.25 | 0.33 | 2.37 | 0.67–8.24 | 0.17 |
| Q5: 76–86 | 8/65 | 1.23 | 0.44–3.46 | 0.69 | 3.19 | 0.90–11.3 | 0.07 |
| | 0.46 | 0.03 | |||||
| BMI (kg/m2) | |||||||
| Q1: 9.91–20.86 (ref.) | 6/72 | 1.00 | 1.00 | - | - | ||
| Q2: 20.87–22.83 | 12/67 | 2.15 | 0.76–6.05 | 0.15 | 2.35 | 0.65–8.43 | 0.19 |
| Q3: 22.84–24.49 | 8/71 | 1.35 | 0.45–4.10 | 0.59 | 1.47 | 0.38–5.60 | 0.58 |
| Q4: 24.50–26.67 | 13/68 | 2.29 | 0.83–6.38 | 0.11 | 2.50 | 0.72–8.75 | 0.15 |
| Q5: 26.68–39.14 | 9/69 | 1.57 | 0.53–4.63 | 0.42 | 3.32 | 0.93–11.9 | 0.07 |
| | 0.46 | 0.09 | |||||
CI: confidence interval; P value < 0.05 were considered significant. Q: quintile.
n1: number of patients with prolonged extubation in each group; n2: number of patients without prolonged extubation in each group.